Friend or Foe: S100 Proteins in Cancer
Allgöwer, Chantal, Kretz, Anna-Laura, von Karstedt, Silvia, Wittau, Mathias, Henne-Bruns, Doris, Lemke, Johannes
Published in Cancers (24.07.2020)
Published in Cancers (24.07.2020)
Get full text
Journal Article
The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma
García-Reyes, Balbina, Kretz, Anna-Laura, Ruff, Jan-Philipp, von Karstedt, Silvia, Hillenbrand, Andreas, Knippschild, Uwe, Henne-Bruns, Doris, Lemke, Johannes
Published in International journal of molecular sciences (18.10.2018)
Published in International journal of molecular sciences (18.10.2018)
Get full text
Journal Article
TRAILblazing Strategies for Cancer Treatment
Kretz, Anna-Laura, Trauzold, Anna, Hillenbrand, Andreas, Knippschild, Uwe, Henne-Bruns, Doris, von Karstedt, Silvia, Lemke, Johannes
Published in Cancers (30.03.2019)
Published in Cancers (30.03.2019)
Get full text
Journal Article
Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy
Kretz, Anna-Laura, von Karstedt, Silvia, Hillenbrand, Andreas, Henne-Bruns, Doris, Knippschild, Uwe, Trauzold, Anna, Lemke, Johannes
Published in Cancers (18.03.2018)
Published in Cancers (18.03.2018)
Get full text
Journal Article
CDK9 is a prognostic marker and therapeutic target in pancreatic cancer
Kretz, Anna-Laura, Schaum, Monika, Richter, Julia, Kitzig, Ella F, Engler, Christine C, Leithäuser, Frank, Henne-Bruns, Doris, Knippschild, Uwe, Lemke, Johannes
Published in Tumor biology (01.02.2017)
Published in Tumor biology (01.02.2017)
Get full text
Journal Article
CK1α overexpression correlates with poor survival in colorectal cancer
Richter, Julia, Kretz, Anna-Laura, Lemke, Johannes, Fauler, Michael, Werner, Jens-Uwe, Paschke, Stephan, Leithäuser, Frank, Henne-Bruns, Doris, Hillenbrand, Andreas, Knippschild, Uwe
Published in BMC cancer (06.02.2018)
Published in BMC cancer (06.02.2018)
Get full text
Journal Article
Evaluation of CDK9 Inhibition by Dinaciclib in Combination with Apoptosis Modulating izTRAIL for the Treatment of Colorectal Cancer
Shen, Xiao, Kretz, Anna-Laura, Schneider, Sandra, Knippschild, Uwe, Henne-Bruns, Doris, Kornmann, Marko, Lemke, Johannes, Traub, Benno
Published in Biomedicines (01.03.2023)
Published in Biomedicines (01.03.2023)
Get full text
Journal Article
The Novel, Orally Bioavailable CDK9 Inhibitor Atuveciclib Sensitises Pancreatic Cancer Cells to TRAIL-induced Cell Death
Ruff, Jan-Philipp, Kretz, Anna-Laura, Kornmann, Marko, Henne-Bruns, Doris, Lemke, Johannes, Traub, Benno
Published in Anticancer research (01.12.2021)
Published in Anticancer research (01.12.2021)
Get full text
Journal Article
Potent pro-apoptotic combination therapy is highly effective in a broad range of cancers
Montinaro, Antonella, Areso Zubiaur, Itziar, Saggau, Julia, Kretz, Anna-Laura, Ferreira, Rute M. M., Hassan, Omar, Kitzig, Ella, Müller, Ines, El-Bahrawy, Mona A., von Karstedt, Silvia, Kulms, Dagmar, Liccardi, Gianmaria, Lemke, Johannes, Walczak, Henning
Published in Cell death and differentiation (01.03.2022)
Published in Cell death and differentiation (01.03.2022)
Get full text
Journal Article